Drugs and Liver Disease: A Tabular Compilation of Drugs and the Histopathological Changes That Can Occur in the Liver

Abstract

A compilation of drugs and the histopathological changes that can occur in the liver is presented. The purpose of this review is to provide the reader with a comprehensive and reliable source of information on various drugs that have been documented by liver biopsy to cause hepatocellular damage. The morphologic terms used in the tables have been chosen based on past publications dealing with this subject. This review is intended as a concise guide to aid in the identification of drug-induced liver diseases.

Keywords

drug-induced diseases hepatic necrosis hepatitis liver hepatocellular changes

Get full access to this article

View all access options for this article.

References

Lesna

Watson

Douglas

, Evaluation of paracetamol-induced damage in liver biopsies. Acute changes and follow-up findings. Virchows Arch (Pathol Anat) 1976; 370: 333–44.

McJunkin

Barwick

Little

, Fatal massive hepatic necrosis following acetaminophen overdose. JAMA 1976; 236: 1874–5.

Bonkowsky

Mudge

McMurtry

. Chronic hepatic inflammation and fibrosis due to low doses of paracetamol. Lancet 1978; 1: 1016–8.

Barker

de Carle

Anuras

Chronic excessive acetaminophen use and liver damage. Ann Intern Med 1977; 87: 299–301.

Portmann

Talbot

Day

, Histopathological changes in the liver following a paracetamol overdose: Correlation with clinical and biochemical parameters. J Pathol 1975; 117: 169–81.

Goldstein

Rothenberg

. Jaundice in a patient receiving acetohexamide. N Engl J Med 1966; 275: 97–9.

Butler

Shah

Grunow

, Massive hepatic necrosis in a patient receiving allopurinol. JAMA 1977; 237: 473–4.

Klastin

Toxic and drug-induced hepatitis. In: Schiff

, ed. Diseases of the liver, 4th ed. Philadelphia: JB Lippincott, 1975: 604–710.

Espiritu

Alalu

Glueckauf

, Allopurinol-induced granulomatous hepatitis. Am J Dig Dis 1976; 21: 804–6.

10.

Simmons

Feldman

Gerety

Granulomatous hepatitis in a patient receiving allopurinol. Gastroenterology 1972; 62: 101–4.

11.

Popper

Rubin

Gardiol

, Drug-induced liver disease. A penalty for progress. Arch Intern Med 1965; 115: 128–36.

12.

Kent

Orfei

Hepatic manifestations of toxic and therapeutic agents. In: Sunderman

Sunderman

Jr , eds. Laboratory diagnosis of diseases caused by toxic agents. St. Louis: Warren H Green, 1970: 460–8

13.

Simpson

Walker

. Hypersensitivity to para-amino-salicylic acid. Am J Med 1960; 29: 297–306.

14.

Cunningham

. Acute hepatic necrosis following treatment with amitriptyline and diazepam. Br J Psychiatry 1965; 111: 1107–9.

15.

Yon

Anuras

Hepatitis caused by amitriptyline therapy. JAMA 1975; 232: 833–4.

16.

Biagi

Bapat

. Intrahepatic obstructive jaundice from amitriptyline. Br J Psychiatry 1967; 113: 1113–4.

17.

Herlong

Reid

Boitnott

, Aprindine hepatitis. Ann Intern Med 1978; 89: 359–61.

18.

Pratt

Johnson

. Duration and severity of fatty metamorphosis of the liver following L-asparaginase therapy. Cancer 1971; 28: 361–4.

19.

Seaman

Ishak

Plotz

. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med 1974; 80: 1–8.

20.

Wolfe

Metzer

Goldstein

. Aspirin hepatitis. Ann Intern Med 1974; 80: 74–6.

21.

Sbarbaro

Bennett

. Aspirin hepatotoxicity and disseminated intravascular coagulation. Ann Intern Med 1977; 86: 183–5.

22.

Hennigar

McMaster

. Granulomatous hepatitis (abstract). Lab Invest 1979; 40: 294.

23.

Zarday

Veith

Gliedman

, Irreversible liver damage after azathioprine. JAMA 1972; 222: 690–1.

24.

Davis

Eddleston

ALWF

. Hypersensitivity and jaundice due to azathioprine. Postgrad Med J 1980; 56: 274–5.

25.

Flippin

Mukherji

Dayal

Granulomatous hepatitis as a late complication of BCG immunotherapy. Cancer 1980; 46: 1759–62.

26.

Aungst

Sokal

Jager

. Complications of BCG vaccination in neoplastic disease. Ann Intern Med 1975; 82: 666–9.

27.

D'Alessandri

Khakoo

. Granulomatous hepatitis in a healthy adult following BCG injection into a plantar wart. Am J Gastroenterol 1977; 68: 392–5.

28.

Hunt

Sparks

Pulch

, Granulomatous hepatitis: A complication of BCG immunotherapy. Lancet 1973; 2: 820–1.

29.

Freundlich

Suprun

Tuberculoid granulomata in the liver after BCG vaccination. Isr J Med Sci 1969; 5: 108–13.

30.

Zucker

Daum

Cohen

. Fatal carbamazepine hepatitis. J Pediatr 1977; 91: 667–8.

31.

Wilson

Belamaric

Lauter

, Anicteric carbenicillin hepatitis. Eight episodes in four patients. JAMA 1975; 232: 818–21.

32.

Amromin

Deliman

Shanbrom

Liver damage after chemotherapy for leukemia and lymphoma. Gastroenterology 1962; 42: 401–10.

33.

Pickering

Hepatic necrosis after chlordiazepoxide therapy (letter). N Engl J Med 1966; 274: 1449.

34.

Abbruzzese

Swanson

Jaundice after therapy with chlordiazepoxide hydrochloride. N Engl J Med 1965; 273: 321–2.

35.

Husebye

. Jaundice with persisting pericholangiolitic inflammation in a patient treated with chlorothiazide. Report of a case. Am J Dig Dis 1964; 9: 439–46.

36.

Schaffner

Raisfeld

. Drugs and the liver: A review of metabolism and adverse reactions. Adv Intern Med 1969; 15: 221–51.

37.

Russell

Allan

Patrick

Active chronic hepatitis after chlorpromazine ingestion. Br Med J 1973; 1: 655–6.

38.

Ishak

Irey

. Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients. Arch Pathol 1972; 93: 283–304.

39.

Levine

Briggs

Lowell

. Chronic chlorpromazine cholangiolitic hepatitis. Gastroenterology 1966; 50: 665–70.

40.

Reichel

Goldberg

Ellenberg

, Intrahepatic cholestasis following administration of chlorpropamide. Report of a case with electron microscopic observations. Am J Med 1960; 28: 654–60.

41.

Rigberg

Robinson

Espiritu

. Chlorpropamide-induced granulomas. A probable hypersensitivity reaction in liver and bone marrow. JAMA 1976; 235: 409–10.

42.

Bateman

Barberio

Cromer

, Investigation of mechanism and type of jaundice produced by large doses of parenterally administered Aureomycin. Antibiot Chemother 1953; 3 (1): 1–15.

43.

Sborov

Sutherland

. Fatty liver following Aureomycin and Terramycin therapy in chronic hepatic disease. Gastroenterology 1951; 18: 598–605.

44.

Parker

JLW

. Potassium clorazepate (Tranxene) induced jaundice. Postgrad Med J 1979; 55: 908–10.

45.

Steinberg

Webb

Rafsky

. Hepatomegaly with fatty infiltration secondary to cortisone therapy: Case report. Gastroenterology 1952; 21: 304–9.

46.

Rosenberg

Edlow

Sneider

Liver disease and vasculitis in a patient taking cromolyn. Arch Intern Med 1978; 138: 989–91.

47.

Aubrey

. Massive hepatic necrosis after cyclophosphamide (letter). Br Med J 1970; 3: 588.

48.

Tolman

Hammar

Sannella

. Possibile hepatotoxicity of doxidan. Ann Intern Med 1976; 84: 290–2.

49.

Wilkinson

Portmann

Williams

Hepatitis from dantrolene sodium. Gut 1979; 20: 33–6.

50.

Donegan

Cohen

. Massive hepatic necrosis associated with dantrolene therapy. Dig Dis Sci 1978; 23 (May suppl): 48–52S.

51.

Utili

Boitnott

Zimmerman

. Dantrolene-associated hepatic injury. Incidence and character. Gastroenterology 1977; 72: 610–6.

52.

Ogburn

Myers

Burdick

. Hepatitis associated with dantrolene sodium. Ann Intern Med 1976; 84: 53–4.

53.

Schneider

Mitchell

Dantrolene hepatitis. JAMA 1976; 235: 1590–1.

54.

Powell

Jr Koch-Weser

Williams

. Lethal hepatic necrosis after therapy with imipramine and desipramine. JAMA. 1968; 206: 642–4.

55.

Morris

Kanner

Chiprut

, Disulfiram hepatitis. Gastroenterology 1978; 75: 100–2.

56.

Kline

. Enflurane-associated hepatitis. Gastroenterology 1980; 79: 126–7.

57.

Vander Reis

Askin

Frecker

, Hepatic necrosis after enflurane anesthesia (letter). JAMA 1974; 227: 76.

58.

Ona

Patanella

Ayub

Hepatitis associated with enflurane anesthesia. Anesth Analg (Cleve) 1980; 59: 146–9.

59.

Sullivan

Csuka

Blanchard

Erythromycin ethylsuccinate hepatotoxicity. JAMA 1980; 243: 1074.

60.

Havens

. Cholestatic jaundice in patients treated with erythromycin estolate. JAMA 1962; 180: 30–2.

61.

Viteri

Greene

Dyck

. Erythromycin ethylsuccinate-induced cholestasis. Gastroenterology 1979; 76: 1007–8.

62.

Zafrani

Ishak

Rudzki

Cholestatic and hepatocellular injury associated with erythromycin esters: Report of nine cases. Dig Dis Sci 1979; 24: 385–96.

63.

Dooner

Hoyl

Aliaga

, Jaundice and oral contraceptives. Acta Hepato-splenol 1971; 18: 84–94.

64.

Conn

Binder

Orr

. Ethionamide-induced hepatitis. A review with a report of an additional case. Am Rev Respir Dis 1964; 90: 542–52.

65.

Kuntz

Liehr

Pfingst

Toxische Liberschädigung durch Athionamid. Dtsch Med Wochenschr 1967; 92: 1718–22.

66.

Nadell

Kosek

Peliosis hepatis. Twelve cases associated with oral androgen therapy. Arch Pathol Lab Med 1977; 101: 405–10.

67.

Walters

Terrence

Steckel

Jaundice following administration of fluphenazine dihydrochloride. Am J Psychiatry 1963; 120: 81–2.

68.

Fang

Ginsberg

Dobbins

III

Cholestatic jaundice associated with flurazepam hydrochloride. Ann Intern Med 1978; 89: 363–4.

69.

Favreau

Tannenbaum

Lough

Hepatic toxicity associated with gold therapy. Ann Intern Med 1977; 87: 717–9.

70.

Griffin

. Cholestatic hepatitis induced by gold. Rheumatol Rehabil 1979; 18: 174–6.

71.

Ghishan

LaBrecque

Younoszai

Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis. Pediatr 1978; 93: 1042–3.

72.

Chiprut

Viteri

Jamroz

, Intrahepatic cholestasis after griseofulvin administration. Gastroenterology 1976; 70: 1141–3.

73.

Peters

Edmondson

Reynolds

, Hepatic necrosis associated with halothane anesthesia. Am J Med 1969; 47: 748–64.

74.

Kaplan

Bakken

Quadracci

, Hepatitis caused by halothane sniffing. Ann Intern Med 1979; 90: 797–8.

75.

Schlipper

Anuras

Recurrent hepatitis following halothane anesthesia. Am J Med 1978; 65: 25–30.

76.

Trey

Lipworth

Chalmers

, Fulminant hepatic failure: Presumable contribution of halothane. N Engl J Med 1968; 279: 798–801.

77.

Thomas

. Chronic aggressive hepatitis induced by halothane. Ann Intern Med 1974; 81: 487–9.

78.

Dordal

Glazov

Orlando

, Fatal halothane hepatitis with transient granulomas. N Engl J Med 1970; 283: 357–9.

79.

Bartoli

Massarelli

Solinas

, Acute hepatitis with bridging necrosis due to hydralazine intake. Arch Intern Med 1979; 139: 698–9.

80.

Jori

Peschle

Hydralazine disease associated with transient granulomas in the liver. A case report. Gastroenterology 1973; 64: 1163–7.

81.

Sternlieb

Robinson

. Stevens-Johnson syndrome plus toxic hepatitis due to ibuprofen. NY State J Med 1978; 78: 1239–43.

82.

Bravo

Jacobsen

Mertens

. Fatty liver and pleural effusion with ibuprofen therapy. Ann Intern Med 1977; 87: 200–1.

83.

Horst

Grace

LeCompte

. Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy. Gastroenterology 1980; 79: 550–4.

84.

Short

Burns

Harris

. Cholestatic jaundice during imipramine therapy. JAMA 1968; 206: 1791–2.

85.

Kelsey

Scharyj

Fatal hepatitis probably due to indomethacin. JAMA 1967; 199: 586–7.

86.

Fenech

Bannister

Grech

. Hepatitis with biliverdinaemia in association with indomethacin therapy. Br Med J 1967; 3: 155–6.

87.

Rosenblum

Korn

Zimmerman

. Hepatocellular jaundice as a complication of iproniazid therapy. Arch Intern Med 1960; 105: 583–93.

88.

Benack

Lynch

Jaundice associated with isocarboxazid therapy. N Engl J Med 1961; 264: 294–5.

89.

Graham

WGB

Dundas

Isoniazid-related liver disease. Occurrence with portal hypertension, hypoalbuminemia and hypersplenism. JAMA 1979; 242: 353–4.

90.

Maddrey

Boitnott

. Isoniazid hepatitis. Ann Intern Med 1973; 79: 1–12.

91.

Black

Mitchell

Zimmerman

. INH-associated hepatitis in 114 patients. Gastroenterology 1975; 69: 289–302.

92.

Mitchell

Zimmerman

Ishak

, Isoniazid liver injury: Clinical spectrum, pathology and probable pathogenesis. Ann Intern Med 1976; 84: 181–92.

93.

Sutherland

Edwards

Medline

, Meglumine iodipamide (Cholografin®) hepatotoxicity. Ann Intern Med 1977; 86: 437–9.

94.

Larsson-Cohn

Stenram

Jaundice during treatment with oral contraceptive agents. Report of two cases. JAMA 1965; 193: 422–6.

95.

Becker

Gordon

Robbins

Hepatitis from methimazole during adrenal steroid therapy for malignant exophthalmos. JAMA 1968; 206: 1787–9.

96.

Almeyda

Barnardo

Baker

Drug reactions. XV. Methotrexate, psoriasis and the liver. Br J Dermatol 1971; 85: 302–5.

97.

Dahl

MGC

Gregory

Scheuer

. Liver damage due to methotrexate in patients with psoriasis. Br Med J 1971; 1: 625–30.

98.

Weinstein

Roenigk

Maibach

, Psoriasisliver-methotrexate interactions. Arch Dermatol 1973; 108: 36–42.

99.

Nyfors

Poulsen

Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotrexate therapy in 88 patients. A blind study. Acta Pathol Microbiol Scand (A) 1976; 84: 262–70.

100.

Podurgiel

McGill

Ludwig

, Liver injury associated with methotrexate therapy for psoriasis. Mayo Clin Proc 1973; 48: 787–92.

101.

Joshi

Conn

. The syndrome of methoxyflurane-associated hepatitis. Ann Intern Med 1974; 80: 395–401.

102.

Rehman

Keith

Gall

. Methyldopa-induced submassive hepatic necrosis. JAMA 1973; 224: 1390–2.

103.

Thomas

Rosenthal

Zapaich

, Spectrum of methyldopa liver injury. Am J Gastroenterol 1977; 68: 125–33.

104.

Schweitzer

Peters

. Acute submassive hepatic necrosis due to methyldopa: A case demonstrating possible initiation of chronic liver disease. Gastroenterology 1974; 66: 1203–11.

105.

Hoyumpa

Jr Connell

. Methyldopa hepatitis. Report of three cases. Am J Dig Dis 1973; 18: 213–22.

106.

Tysell

Jr Knauer

. Hepatitis induced by methyldopa (Aldomet®). Report of a case and a review of the literature. Am J Dig Dis 1971; 16: 849–55.

107.

Miller

Jr Reid

. Methyldopa-induced granulomatous hepatitis. JAMA 1976; 235: 2001–2.

108.

Glober

Wilkerson

. Biliary cirrhosis following the administration of methyltestosterone. JAMA 1968; 204: 170–3.

109.

Hennigan

McMaster

. Granulomatous hepatitis (abstract). Lab Invest 1979; 40: 294.

110.

Ream

Perlia

Walter

, Mithramycin therapy in disseminated germinal testicular cancer. JAMA 1968; 204: 1030–6.

111.

Kennedy

. Metabolic and toxic effects of mithramycin during tumor therapy. Am J Med 1970; 49: 494–503.

112.

Moertel

Reitemeier

Hahn

. Mitomycin C therapy in advanced gastrointestinal cancer. JAMA 1968; 204: 1045–8.

113.

Kenis

Stryckmans

Action de la mitomycin C dans 65 cas de tumeurs malignes. Comparaison de l'effet de doses faibles répétées et de doses “massives.”

Chemotherapia 1964; 8: 114–30.

114.

Victorino

RMM

Silveira

JCB

Baptista

, Jaundice associated with naproxen. Postgrad Med J 1980; 56: 368–70.

115.

Parsons

Jr.

Studies of nicotinic acid use in hypercholesteremia. Arch Intern Med 1961; 107: 653–67.

116.

Berge

Achor

RWP

Christensen

, Hypercholesteremia and nicotinic acid. A long term study. Am J Med 1961; 31: 24–36.

117.

Kohn

Montes

Hepatic fibrosis following long acting nicotinic acid therapy. A case report. Am J Med Sci 1969; 258: 94–9.

118.

Hatoff

Cohen

Schweigert

Nitrofurantoin: Another cause of drug-induced chronic active hepatitis?. Am J Med 1979; 67: 117–21.

119.

Iwarson

Lindberg

Lundin

Nitrofurantoin-induced chronic liver disease. Clinical cause and outcome of five cases. Scand J Gastroenterol 1979; 14 (4): 497–502.

120.

Goldstein

Ishak

Burns

Hepatic injury associated with nitrofurantoin therapy. Am J Dig Dis 1974; 19: 987–98.

121.

Klemola

Penttila

Runeberg

, Anicteric liver damage during nitrofurantoin medication. Scand J Gastroenterol 1975; 10 (5): 501–5.

122.

Stromberg

Wengle

Chronic active hepatitis induced by nitrofurantoin. Br Med J 1976; 2: 174–5.

123.

Sharp

Ishak

Zimmerman

. Chronic active hepatitis in recipients of nitrofurantoin. Ann Intern Med 1980; 92: 14–19.

124.

Ernaelsteen

Williams

Jaundice due to nitrofurantoin. Gastroenterology 1961; 41: 590–3.

125.

Bruckstein

Attia

. Oxacillin hepatitis. Two patients with liver biopsy and review of the literature. Am J Med 1978; 64: 519–22.

126.

Ten Pas

Quinn

. Cholestatic hepatitis following the administration of sodium oxacillin. JAMA 1965; 191: 674–5.

127.

Lundquist

Discussion of paper by Sherlock S. Drugs and the liver. In: Engel

Larson

, eds. Alcoholic cirrhosis and other toxic hepatopathies. Stockholm: Nordiska Bokhandelns Förlag, 1970: 249–50.

128.

Ronnov-Jessen

Tjerlund

Hepatotoxicity due to treatment with papaverine. N Engl J Med 1969; 281: 1333–5.

129.

Pathy

Reynolds

. Papaverine hepatotoxicity. Postgrad Med J 1980; 56: 488–90.

130.

Goldstein

Ishak

. Hepatic injury associated with penicillin therapy. Arch Pathol 1974; 98: 114–7.

131.

Waugh

Myocarditis, arteritis, and focal hepatic, splenic and renal granulomas apparently due to penicillin sensitivity. Am J Pathol 1952; 28: 437–47.

132.

Chajek

Geltner

Levij

Quinidine-induced granulomatous hepatitis. Ann Intern Med 1974; 81: 774–6.

133.

Paliard

Vitrey

Fournier

, Perhexiline maleate-induced hepatitis. Digestion 1978; 17 (5): 419–27.

134.

Poupon

Rosensztajn

de Saint-Maur

P Prudhomme

Perhexiline maleate-associated hepatic injury prevalence and characteristics. Digestion 1980; 20 (3): 145–50.

135.

Lewis

Wainwright

Kew

, Liver damage associated with perhexiline maleate. Gut 1979; 20: 186–9.

136.

Berkowitz

Rotman

Greenstein

, Occurrence of jaundice during treatment with perphenazine and beta-phenyliso-propylhydrazine. Am J Dig Dis 1961; 6: 160–5.

137.

Goldfinger

Marx

Hypersensitivity hepatitis due to phenazopyridine hydrochloride. N Engl J Med 1972; 286: 1090–1.

138.

Cook

Sherlock

Jaundice and its relationship to therapeutic agents. Lancet 1965; 1: 175–9.

139.

McGeachy

Bloomer

. The phenobarbital sensitivity syndrome. Am J Med 1953; 14: 600–4.

140.

Pagliaro

Campesi

Aguglia

Barbiturate jaundice. Report of a case due to barbital containing drug, with positive rechallenge to phenobarbital. Gastroenterology 1969; 56: 938–43.

141.

Slagboom

Loeliger

. Coumarin-associated hepatitis. Arch Intern Med 1980; 140: 1028–9.

142.

Den Boer

Loeliger

. Phenprocoumon-induced jaundice (letter). Lancet 1976; 1: 912.

143.

Engelman

Krupp

Rinehart

, Hepatitis following the ingestion of phenylbutazone. JAMA 1954; 156: 98–101.

144.

Ishak

Kirchner

Dhar

. Granulomas and cholestatic-hepatocellular injury associated with phenylbutazone. Report of two cases. Am J Dig Dis 1977; 22: 611–7.

145.

Lee

Carney

Lapis

, Diphenylhydantoin-induced hepatic necrosis. A case study. Gastroenterology 1976; 70: 422–4.

146.

Harinasuta

Zimmerman

. Diphenylhydantoin sodium hepatitis. JAMA 1968; 203: 1015–8.

147.

Campbell

McGuffie

Weedon

, Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism. Am J Dig Dis 1977; 22: 255–62.

148.

Hamlyn

Morris

Sarkany

, Piperazine hepatitis. Gastroenterology 1976; 70: 1144–7.

149.

Reynolds

Schlant

Gonick

, Fatal massive necrosis of the liver as a manifestation of hypersensitivity to probenecid. N Engl J Med 1957; 256: 592–6.

150.

Rotmensch

Yust

Siegman-Igra

, Granulomatous hepatitis: A hypersensitivity response to procainamide. Ann Intern Med 1978; 89: 646–7.

151.

McFarland

. Fatal drug reaction associated with prochlorperazine (Compazine®). Am J Clin Pathol 1963; 40: 284–90.

152.

Mechanic

Meyers

Chlorpromazine-type cholangitis. Report of a case occurring after the administration of prochlorperazine. N Engl J Med 1958; 259: 778–80.

153.

Klein

Magida

. Propoxyphene (Davron®) hepatotoxicity. Am J Dig Dis 1971; 16: 467–9.

154.

Eisen

. Fulminant hepatitis during treatment with propylthiouracil. N Engl J Med 1953; 249: 814–6.

155.

Mihas

Holley

Koff

, Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. Gastroenterology 1976; 70: 770–4.

156.

Fedotin

Lefer

. Liver disease caused by propylthiouracil. Arch Intern Med 1975; 135: 319–21.

157.

Parker

. Hepatitis and propylthiouracil (letter). Ann Intern Med 1975; 829: 228–9.

158.

Hutchinson

Roediger

Werblin

Cholestatic jaundice following administration of quinethazone. Curr Ther Res 1964; 6: 199–201.

159.

Koch

Seeff

Crumley

, Quinidine hepatotoxicity. A report of a case and review of the literature. Gastroenterology 1976; 70: 1136–40.

160.

Geltner

Chajek

Rubinger

, Quinidine hypersensitivity and liver involvement. A survey of 32 patients. Gastroenterology 1976; 70: 650–2.

161.

Bramlet

Posalaky

Olson

Granulomatous hepatitis as a manifestation of quinidine hypersensitivity. Arch Intern Med 1980; 140: 395–7.

162.

Pessayre

Bentata

Degott

, Isoniazidrifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology 1977; 72: 284–9.

163.

Norgren

Spontaneous rupture of liver and spleen during streptokinase treatment of deep vein thrombosis (abstract). Lakartidningen 1978; 75: 777–8.

164.

Herbut

Scaricaciottolo

. Diffuse hepatic necrosis caused by sulfadiazine. Arch Pathol 1945; 40: 94–8.

165.

Tonder

Nordöy

Elgjo

Sulfonamide-induced chronic liver disease. Scand J Gastroenterol 1974; 9 (1): 93–6.

166.

Dujovne

Chan

Zimmerman

. Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole. N Engl J Med 1967; 277: 785–8.

167.

Sotolongo

Neefe

Rudzki

, Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity. Gastroenterology 1978; 75: 95–9.

168.

Gulby

Mirza

Kelly

. Hepatotoxicity of salicylazosulfapyridine. Am J Gastroenterol 1979; 72: 561–4.

169.

Rafoth

. Systemic granulomatous reaction to salicylazosulfapyridine (Azulfidine®) in a patient with Crohn's disease. Am J Dig Dis 1974; 19: 465–9.

170.

McMillan

Diff

. The pathology of sulfonamide allergy in man. Am J Pathol 1946; 22: 703–25.

171.

Robinson

Rywlin

. Tetracycline associated fatty liver in the male. Report of an autopsied case. Am J Dig Dis 1970; 15: 857–62.

172.

Reinhart

Benson

Kwass

, Suggestive evidence of hepatotoxicity concomitant with thioridazine hydrochloride use. JAMA 1966; 197: 767–9.

173.

Loludice

Lang

. Tolazamide-induced hepatic dysfunction. Am J Gastroenterol 1978; 69: 81–3.

174.

Van Thiel

deBelle

Mellow

, Tolazamide hepatotoxicity. A case report. Gastroenterology 1974; 67: 506–10.

175.

Hamff

Ferris

Evans

, The effects of tolbutamide and chlorpropamide on patients exhibiting jaundice as a result of previous chlorpropamide therapy. Ann NY Acad Sci 1959; 74: 820–9.

176.

Gregory

Zaki

Sarcosi

, Chronic cholestasis following prolonged tolbutamide administration. Arch Pathol 1967; 84: 194–201.

177.

Bandt

Hoffbauer

. Liver injury associated with tranylcypromine therapy. JAMA 1964; 188: 752–3.

178.

Kohn

Myerson

. Cholestatic hepatitis associated with trifluoperazine. N Engl J Med 1961; 264: 549–50.

179.

Borda

Jick

Hepatitis following the administration of trimethobenzamide hydrochloride. Arch Intern Med 1967; 120: 371–3.

180.

Bjorneboe

Iversen

Olsen

Infective hepatitis and toxic jaundice in a municipal hospital during a five-year period. Incidence and prognosis. Acta Med Scan 1967; 182: 491–501.

181.

Suchy

Balistreri

Buchino

, Acute hepatic failure associated with the use of sodium valproate. N Engl J Med 1979; 300: 962–6.

182.

Sparberg

Simon

del Greco

Intrahepatic cholestasis due to azathioprine. Gastroenterology 1969; 57: 439–41.

183.

Marubbio

Danielson

Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine. Gastroenterology 1975; 69: 739–43.

184.

Degott

Rueff

Kreis

, Peliosis hepatis in recipients of renal transplants. Gut 1978; 19: 748–53.

185.

Underwood

JCE

Shahani

Blackburn

. Jaundice after treatment of leukemia with busulfan. Br Med J 1971; 1: 556–7.

186.

Ramsay

. Carbamazepine-induced jaundice. Br Med J 1967; 4: 155.

187.

Levy

Bouma

Lageron

, Hepatic sinusoidal dilatation after chenodeoxycholic acid therapy (letter). Lancet 1978; 1: 206.

188.

Bolton

. Prolonged chlorpromazine jaundice. Am J Gastroenterol 1967; 48: 497–503.

189.

Gambesicia

Imbriglia

Galamaga

, Jaundice associated with the administration of chlorpromazine. Gastroenterology 1956; 30: 735–51.

190.

Somani

Munoz

A case of unexplained jaundice. Drug Ther 1978; 8: 63–70.

191.

Enat

Pollack

Ben-Arieh

, Cholestatic jaundice caused by cloxacillin: Macrophage inhibition test in preventing rechallenge with hepatotoxic drug. Br Med J 1980; 1: 982–3.

192.

Taxy

. Peliosis: A morphologic curiosity becomes an iatrogenic problem. Hum Pathol 1978; 9: 331–40.

193.

Griner

Elbadauri

Packman

. Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Ann Intern Med 1967; 85: 578–82.

194.

McLeod

Kinsella

. Cholestasis associated with D-penicillamine therapy for rheumatoid arthritis. Can Med Assoc J 1979; 120: 965–6.

195.

Puppala

. Possible association between peliosis hepatis and diethylstilbestrol. Postgrad Med 1979; 65: 277–81.

196.

Hoch-Ligeti

Angiosarcoma of the liver associated with diethylstilbestrol. JAMA 1978; 240: 1510–1.

197.

Craxi

Gatto

Maringhini

, Disopyramide and cholestasis (letter). Ann Intern Med 1980; 93 (part I): 150–1.

198.

Riccioni

Bozzi

Susini

, Disopyramide-induced intrahepatic cholestasis (letter). Lancet 1977; 2: 1362–3.

199.

Meinertz

Langer

Kasper

, Disopyramide-induced intrahepatic cholestasis (letter). Lancet 1977; 2: 828–9.

200.

Gottschall

CAM

Cunha

Miller

Disopyramide jaundice. Rev Assoc Med Rio Grande Sul 1970; 14: 195–6.

201.

Tsang

. Jaundice after enflurane anesthesia. Ill Med J 1975; 148: 593–4.

202.

Larsson-Cohn

Stenram

Liver ultrastructure and function in icteric and non-icteric women using oral contraceptive agents. Acta Med Scand 1967; 181: 257–64.

203.

Winkler

Poulsen

Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand J Gastroenterol 1975; 10 (7): 699–704.

204.

Spurny

Klotz

. Budd-Chiari syndrome after taking oral contraceptives. A case report and review of 14 reported cases. Am J Dig Dis 1977; 22: 623–8.

205.

Kew

Van Coller

Prowse

, Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids. S Afr Med J 1976; 50 (32): 1233–7.

206.

Trias

Rius

Autonell

, Hepatocarcinoma and oral contraceptive (letter). Lancet 1978; 1: 821.

207.

Davis

Postmann

Searle

, Histological evidence of carcinoma in a hepatic tumor associated with oral contraceptives. Br Med J 1975; 4: 496–8.

208.

Klastin

Hepatic tumors: Possible relationship to use of oral contraceptives. Gastroenterology 1977; 73: 386–94.

209.

Sole

Lerner

. Multiple tumors after androgen therapy. Arch Pathol Lab Med 1977; 101: 600–3.

210.

Holder

Gnarra

Lampkin

, Hepatoma associated with anabolic steroid therapy. Am J Roentgenol Radium Ther Nucl Med 1975; 124: 638–42.

211.

Snyder

Fluphenazine jaundice. Am J Gastroenterol 1980; 73: 336–40.

212.

Klastin

Kimber

. Recurrent hepatitis attributable to halothane sensitization in an anesthetist. N Engl J Med 1969; 280: 515–20.

213.

Tigano

Ferlazzo

Barrile

Oral contraceptives and malignant hepatoma. Lancet 1976; 2: 196.

214.

Einhorn

Davidsohn

Hepatotoxicity of mercaptopurine. JAMA 1964; 188: 802–6.

215.

Krawitt

Stein

Kirkendall

, Mercaptopurine hepatotoxicity in a patient with chronic active hepatitis. Arch Intern Med 1967; 120: 729–34.

216.

Mays

Christopherson

Mahr

, Hepatic changes in young women ingesting contraceptive steroids: Hepatic hemorrhage and primary hepatic tumors. JAMA 1976; 275: 730–2.

217.

Glassberg

Rosenbaum

. Oral contraceptives and malignant hepatoma. Lancet 1976; 1: 479–80.

218.

Meyer

Livolsi

Cornog

. Hepatoblastoma associated wtih oral contraceptives. Lancet 1974; 2: 1387.

219.

Usatin

Wigger

. Peliosis hepatis in a child. Arch Pathol Lab Med 1976; 100: 419–21.

220.

Johnson

Feagler

Lerner

, Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 1972; 2: 1273–6.

221.

Ruymann

Mosijczuk

Sayers

. Hepatoma in a child with methotrexate-induced hepatic fibrosis. JAMA 1977; 238: 2631–3.

222.

Shashaty

. Cryptogenic cirrhosis associated with methyldopa. South Med J 1979; 72: 364–6.

223.

Sweeney

Evans

. Hepatic lesions in patients treated with synthetic anabolic steroids. J Clin Pathol 1976; 29: 626–33.

224.

Paradinas

Bull

Westaby

, Hyperplasia and prolapse of hepatocytes into hepatic veins during long-term methyltestosterone therapy: Possible relationships of these changes to the development of peliosis hepatis and liver tumors. Histopathology 1977; 1: 255–46.

225.

Bird

Vowles

KDJ

. Liver damage from long term methyltestosterone. Lancet 1977; 2: 400–1.

226.

Boyd

Mark

. Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyltestosterone for eleven years. Cancer 1977; 40: 1765–70.

227.

Recant

Lacey

Fanconi's anemia and hepatic cirrhosis. Clinico-pathologic conference. Am J Med 1965; 39: 464–75.

228.

Zeigenfuss

Carabasi

Androgens and hepatocellular carcinoma. Lancet 1973; 1: 262.

229.

Henderson

Richmond

Sumerling

. Androgenic-anabolic steroid therapy and hepatocellular carcinoma. Lancet 1973; 1: 934.

230.

Farrell

Joshua

Uren

, Androgen-induced hepatoma. Lancet 1975; 1: 430–2.

231.

Goodman

Laden

AMJ

. Hepatocellular carcinoma in association with androgen therapy. Med J Aust 1977; 1: 220–1.

232.

Westaby

Ogle

Paradinas

, Liver damage from long term methyltestosterone. Lancet 1977; 2: 261–3.

233.

Meadows

Naiman

Valdes-Dapena

Hepatoma associated with androgen therapy for aplastic anemia. J Pediatr 1974; 84: 109–10.

234.

Sarna

Tomasulo

Lotz

, Multiple neoplasms in two siblings with a variant form of Fanconi's anemia. Cancer 1975; 36: 1029–33.

235.

Hoyumpa

Jr Schiff

Helfman

. Budd-Chiari syndrome in women taking oral contraceptives. Am J Med 1971; 50: 137–40.

236.

Zafani

Ishak

. Hepatic venous outflow obstruction. A report of 82 cases of Budd-Chiari syndrome and veno-occlusive disease. In press.

237.

Pryor

Cohen

Goldman

. Hepatocellular carcinoma in a woman on long term contraceptives. Cancer 1977; 40: 884–8.

238.

Neuberger

Nunnerley

Davis

, Oral contraceptive associated liver tumors: Occurrence of malignancy and difficulties in diagnosis. Lancet 1980; 1: 273–6.

239.

Nissen

Kent

Nissen

, Association of liver tumors with oral contraceptives. Obstet Gynecol 1976; 48: 49–55.

240.

Edmondson

Henderson

Benton

Liver-cell adenomas associated with the use of oral contraceptives. N Engl J Med 1976; 274: 470–2.

241.

Rooks

Ory

Ishak

, The association between oral contraception and hepatocellular adenoma. A preliminary report. Int J Gynecol Obstet 1977; 15 (2): 143–4.

242.

Thalassinas

Lymberatos

Hadjioannou

, Liver cell carcinoma after long term oestrogen-like drugs. Lancet 1974; 1: 270–1.

243.

O'Sullivan

Rosswick

. Oral contraceptives and liver tumours. Lancet 1976; 1: 1124–5.

244.

Mokrohisky

Ambruso

Hathaway

. Fulminant hepatic neoplasia after androgen therapy. N Engl J Med 1977; 296: 1411–2.

245.

McDonald

Speicher

. Peliosis hepatis associated with administration of oxymetholone. JAMA 1978; 240: 243–4.

246.

Port

Patasnick

Ranniger

Angiographic demonstration of hepatoma in association with Fanconi's anemia. Am J Roentgenol 1971; 113: 82–3.

247.

Bernstein

Hunter

Yachnin

Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia. N Engl J Med 1971; 284: 1135–6.

248.

Mulvihill

Ridolfi

Schultz

, Hepatic adenoma in Fanconi anemia treated with oxymetholone. J Pediatr 1975; 87: 122–4.

249.

Johnson

. Androgenic-anabolic steroids and hepatocellular carcinoma. In: Okuda

Peters

, eds. Hepatocellular carcinoma. New York: John Wiley and Sons, 1976: 95–103.

250.

Bruguera

Hepatoma associated with androgenic steroids. Lancet 1975; 1: 1294–5.

251.

Lesna

Spencer

Wolker

Liver nodules and androgens. Lancet 1976; 1: 1124–5.

252.

Sweeney

Evans

. Liver lesions and androgenic steroid therapy. Lancet 1975; 2: 1042.

253.

Pessayre

Bichara

Feldmann

, Perhexiline maleate-induced cirrhosis. Gastroenterology 1979; 76: 172–7.

254.

Daneshmend

Scott

Bradfield

JWB

. Angiosarcoma of liver associated with phenelzine. Br Med J 1979; 1: 1979.

255.

Weinstein

Alper

Dade

. Cholestasis due to prochlorperazine. JAMA 1959; 170: 1663–4.

256.

Weiss

Hassin

Bank

Propylthiouracil-induced hepatic damage. Arch Intern Med 1980; 140: 1184–5.

257.

Ticktin

Zimmerman

. Hepatic dysfunction and jaundice in patients receiving triacetyloleandomycin. N Engl J Med 1962; 267: 964–8.

258.

Miguet

Viutton

Pessayre

, Jaundice from troleandomycin and oral contraceptives (letter). Ann Intern Med 1980; 92: 434.

259.

Nair

Kaplan

Levine

, Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis. Ann Intern Med 1980; 92: 511–2.

260.

Russell

Boyer

Bagheri

, Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites. N Engl J Med 1974; 291: 435–40.

261.

Rehnquist

Intrahepatic jaundice due to warfarin therapy. Acta Med Scand 1978; 204: 335–6.

262.

Villeneuve

Warner

. Cimetidine hepatitis. Gastroenterology 1979; 77: 143–4.

263.

Lorenzini

Jezequel

Orlandi

Cimetidine-induced hepatitis. Electron microscopic observations and clinical pattern of liver injury. Dig Dis Sci 1981; 26: 275–80.

264.

Spiegel

Pizzo

Fantone

, Fatal hepatic necrosis after high dose chemotherapy following haloalkane anesthesia. Cancer Treat Rep 1980; 64: 1023–9.

265.

Ludin

Uden

Hanson

. Dantrolene-associated hepatitis. Drug Intell Clin Pharm 1977; 11: 278–80.

266.

Miller

Dwyer

Klatskin

Halothane hepatitis: Benign resolution of a severe lesion. Ann Intern Med 1978; 89: 212–5.

267.

Evans

Self

Weisburst

. Phenobarbital-induced hepatic dysfunction. Drug Intell Clin Pharm 1976; 10: 439–43.

268.

Goldstein

Granoff

Waisman

Hepatic injury due to oxacillin administration. Am J Gastroenterol 1978; 70: 171–4.

269.

Elmore

Rissing

Rink

, Clindamycin-associated hepatotoxicity. Am J Med 1974; 57: 627–30.

270.

Chawla

Patel

Parrino

, Allopurinol hepatotoxicity. Arthritis Rheum 1977; 20: 1546–9.

271.

Swank

Chejfec

Nemchausky

. Allopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction. Arch Intern Med 1978; 138: 997–9.

272.

Reynolds

Lloyd

Slinger

. Cholestatic jaundice induced by flurazepam hydrochloride. Can Med J 1981; 124: 893–4.

273.

Belt

McGregor

Haas

, Cholestatic jaundice associated with chlorozotocin. Cancer Treat Rep 1980; 64: 1235–9.

274.

Ransohoff

Jacobs

Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. Gastroenterology 1981; 80: 816–9.

275.

Camilleri

Schafler

Chadwick

, Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology 1981; 80: 810–5.

276.

Siebold

Lynch

Medsger

. Cholestasis associated with D-penicillamine therapy: Case report and review of the literature. Arthritis Rheum 1981; 24: 554–6.

277.

White

DeTarnowsky

Mir

, Hepatotoxicity following enflurane anesthesia. Dig Dis Sci 1981; 26: 466–9.

278.

Wongpaitoon

Mills

Russell

, Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy. Postgrad Med J 1981; 57: 244–6.

279.

Williams

Malatjalian

. Severe penicillin-induced cholestasis in a 91-year-old woman. Dig Dis Sci 1981; 26: 470–3.

280.

Parker

Shearer

. Phenytoin hepatotoxicity: A case report and review. Neurology 1979; 29: 175–8.

281.

Greenstone

Dowd

Mikhailidis

, Hepatic vascular lesions associated with dacarbazine treatment. Br Med J 1981; 282: 1744–5.

282.

Ogilvie

Toghill

. Cholestatic jaundice due to co-trimoxazole. Postgrad Med J 1980; 56: 202–4.

283.

Levy

Goodman

Van Dyne

, Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med 1981; 95: 64–5.

284.

Krivoy

Ben-Arieh

Carter

, Methazolamide-induced hepatitis and pure RBC aplasia. Arch Intern Med 1981; 141: 1229–30.

285.

Multz

. Cholestatic hepatitis caused by penicillamine. JAMA 1981; 246: 674–5.

286.

Sippel

Agger

. Nitrofurantoin-induced granulomatous hepatitis. Urology 1981; 18: 177–8.

287.

Shi

ECP

Fischer

Crouch

, Possible association of angiosarcoma with oral contraceptive agents. Med J Aust 1981; 1: 473–4.

288.

Steinbrecher

Mishkin

Sulfamethoxazole-induced hepatic injury. Dig Dis Sci 1981; 26: 756–9.

289.

Martin

Rickers

Cholestatische Hepatose nach Diphenylhydantoin. Wien Klin Wochenschr 1972; 84: 41–5.

290.

Weedon

. Diphenylhydantoin sensitivity: A syndrome resembling infectious mononucleosis with a morbilliform rash and cholestatic hepatitis. Aust NZ J Med 1975; 5: 561–3.

291.

Berlinger

Spector

Flanigan

, Hemoperfusion for phenylbutazone poisoning. Ann Intern Med 1982; 96: 334–5.

292.

Spechler

Sperber

Doos

, Cholestasis and toxic epidermal necrolysis associated with phenytoin sodium ingestion: The role of bile duct injury. Ann Intern Med 1981; 95: 455–6.

293.

Mullick

Ishak

. Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases. Am J Clin Pathol 1980; 74: 442–52.

294.

Mitchell

Boitnott

Arregui

, Granulomatous hepatitis associated with carbamazepine. Am J Med 1981; 71: 733–5.

295.

Heiberg

Svejgaard

Toxic hepatitis during ketoconazole treatment. Br Med J 1981; 283: 825–6.

296.

Fortwengler

Jones

Espinosa

, Evidence for endothelial cell origin of vinyl chloride-induced hepatic angiosarcoma. Gastroenterology 1981; 80: 1415–9.

297.

Tiliakos

Waites

. Multiform quinidine toxicity. South Med J 1981; 74: 1267–8.

298.

Al-Kawas

Seeff

Berendson

, Allopurinol hepatotoxicity: Report of two cases and review of the literature. Ann Intern Med 1981; 95: 588–90.

299.

Steinbrecher

Lisbona

Huang

, Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 1981; 26: 1045–50.

300.

Danan

Pessayre

Larrey

, Pyrazinamide fulminant hepatitis: An old hepatotoxin strikes again (letter). Lancet 1981; 2: 1056–7.

301.

Coto

McGowan

Pierce

Intrahepatic cholestasis due to trimethoprim-sulfamethoxazole. South Med J 1981; 74: 897–8.

302.

Shuck

Shen

Owensby

, Spironolactone hepatitis in primary hyperaldosteronism. Ann Intern Med 1981; 95: 708–9.

303.

Cobden

Record

White

RWB

. Fatal intrahepatic cholestasis associated with triazolam. Postgrad Med J 1981; 57: 730–1.

304.

Roberts

Cohn

Petroff

, Liver disease induced by perhexiline maleate. Med J Aust 1981; 2: 553–4.

305.

Cocks

. Methyltestosterone-induced liver-cell tumours. Med J Aust 1981; 2: 617–8.

306.

Rotmensch

Yust

Siegman-Igra

, Granulomatous hepatitis: A hypersensitivity response to procainamide. Ann Intern Med 1978; 89: 646–7.

307.

Hopen

Nesthus

Laerum

. Fatal carbamazepine-associated hepatitis. Acta Med Scand 1981; 210: 333–5.

308.

Abi-Mansur

Ardiaca

Allam

, Trimethoprim-sulfamethoxazole-induced cholestasis. Am J Gastroenterol 1981; 76: 356–9.

309.

Sutherland

Muller

Lewis

. Massive cerebral edema associated with fulminant hepatic failure in acetaminophen overdose. Am J Gastroenterol 1981; 76: 446–8.

310.

Shar

Kew

. Oral contraceptives and hepatocellular carcinoma. Cancer 1982; 49: 407–10.

311.

Weber

Mitchell

Powell

, Reversible hepatotoxicity associated with hepatic vitamin A accumulation in a protein-deficient patient. Gastroenterology 1982; 82: 118–23.

312.

Bezahler

. Fatal methyldopa-associated granulomatous hepatitis and myocarditis. Am J Med Sci 1982; 283: 41–5.

313.

Gill

Onstad

Cardamone

, Hepatic veno-occlusive disease caused by 6-thioguanine. Ann Intern Med 1982; 96: 58–60.